Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01681888

Surface EMG Biofeedback for Children With Cerebral Palsy

Clinical Trial of Surface EMG Biofeedback for Children With Cerebral Palsy and Associated Movement Disorders

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
University of Southern California · Academic / Other
Sex
All
Age
0 Years – 21 Years
Healthy volunteers
Not accepted

Summary

Movement disorders such as dystonia, hypertonia, and spasticity interfere with or prevent voluntary movement. Studies have suggested that using biofeedback to increase awareness of muscle activation can improve motor function in patients with motor deficits. The investigators hypothesize that the daily use of a surface electromyographic (SEMG) biofeedback device for one month will improve motor function in children and young adults with dystonia, hypertonia, and/or spasticity. The SEMG biofeedback device is worn over the muscle(s) the subject has difficulty in controlling and provides vibratory feedback about muscle activation. Groups of children and young adults (ages 3-21), with dystonia, hypertonia, and/or spasticity will be asked to wear a small (approx 1 square inch) sensory feedback device on their affected muscle(s) for 5 hours a day for one month. The device will vibrate and emit a blue light when the muscle is activated. At the start of the experiment, subjects will be tested on the Goal Attainment Scale (GAS), the Pediatric/Adolescent Outcomes Data Collections Instruments (PODCI), and the Barry Albright Dystonia Scale (BAD). For one month, subjects will practice goals without device. After a month, subject will be assessed again and be given device to practice goals for a month. After one month, the subjects will be tested on the outcome measures again and return device.

Conditions

Interventions

TypeNameDescription
DEVICESanger EMG Biofeedback Device

Timeline

Start date
2012-05-01
Primary completion
2024-02-22
Completion
2024-02-22
First posted
2012-09-10
Last updated
2024-02-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01681888. Inclusion in this directory is not an endorsement.